Revenue - Generated group revenues of approximately A$6.5 million in FY20, the UK business howeverwas only operating for a nine-month periodand contributed revenues of£2.2 million during this time– Quarterly Report is due by 30thApril.
Unique – Health House is the only listed distributor of medicinal cannabis and pharmaceutical products on the ASX.
Distribution–Subsidiary HHI (Australia) Pty Ltddistributes medicinal cannabis products to almost 700 pharmacies, over 200 doctors and eight specialist medicinal cannabis clinics. GMP certified medicinal cannabis manufacturers and suppliers including, Aurora/Cannimed, Little Green Pharma, Satipharm, Zelira Therapeutics, IX Biopharma, HAPA Pharm, Bedrocan, Turkken and Levin Health.
Capital Structure – Only 59M shares are tradable with the remainder of stock Escrow for 12-24 months, fully diluted HHI will have a market capitalisation of~$31M at 20c or an EV of ~$24M
Growing - The medicinal cannabis sector is a large and growing market (articles below):
